Department of Chemistry, Brooklyn College of the City University of New York, Brooklyn, New York 11210, United States.
Ph.D. Program in Biochemistry, The Graduate Center of the City University of New York, 365 Fifth Avenue, New York, New York 10016, United States.
J Org Chem. 2024 Sep 20;89(18):12873-12885. doi: 10.1021/acs.joc.4c01305. Epub 2024 Sep 4.
Photooxidative damage is heavily influenced by the presence of bioactive agents. Conversely, bioactive agents influence the local environment, which in turn is perturbed by photooxidative damage. These sorts of processes give rise to a version of the "chicken-and-egg" quandary. In this Perspective, we probe this issue by referring to photooxidative damage in one direction as the light-dark (L-D) sequence and in a second direction as the dark-light (D-L) sequence with a reversed cause and effect. The L-D sequence can lead to the downstream production of reactive molecular species (RMS) in the dark, whereas the D-L sequence can be a pre-irradiation period, such as an additive to limit cellular iron levels to enhance biosynthesized amounts of a protoporphyrin sensitizer. A third direction comes from L-D or D-L sequences, or both simultaneously, which can also be useful for optimizing photodynamics. Photodynamic optimization will benefit from understanding and quantitating unidirectional L-D and D-L pathways, and bidirectional L-D/D-L pathways, for improved control over photooxidative damage. Photooxidative damage, which occurs during anticancer photodynamic therapy (PDT), will be shown to involve RMS. Such RMS include persulfoxides (RSOO), NO, peroxynitrate (ONOO), OOSCN, SO, selenocyanogen [(SeCN)], the triselenocyanate anion [(SeCN)], I, I, I, and HOOI, as well as additives to destabilize membranes (e.g., caspofungin and saponin A16), inhibit DNA synthesis (5-fluorouracil), or sequester iron (desferrioxamine). In view of the success that additive natural products and repurposed drugs have had in PDT, a Perspective of additive types is expected to reveal mechanistic details for enhanced photooxidation reactions in general. Indeed, strategies for how to potentiate photooxidations with additives remain highly underexplored.
光氧化损伤受生物活性物质的存在严重影响。相反,生物活性物质会影响局部环境,而局部环境又会受到光氧化损伤的干扰。这些过程引发了一种“先有鸡还是先有蛋”的困境。在本文中,我们通过将光氧化损伤在一个方向上称为光-暗(L-D)序列,在另一个方向上称为暗-光(D-L)序列,并反转因果关系来探究这个问题。L-D 序列可以导致暗区中活性分子物质(RMS)的下游产生,而 D-L 序列可以是预辐照期,例如添加物来限制细胞铁水平以增强原卟啉敏化剂的生物合成量。第三个方向来自 L-D 或 D-L 序列,或两者同时作用,这也有助于优化光动力学。光动力学的优化将受益于理解和量化单向 L-D 和 D-L 途径,以及双向 L-D/D-L 途径,以更好地控制光氧化损伤。光氧化损伤发生在癌症光动力治疗(PDT)中,将涉及 RMS。这些 RMS 包括过硫酸盐(RSOO)、NO、过氧亚硝酸盐(ONOO)、OOSCN、SO、硒氰根[(SeCN)]、三硒氰根阴离子[(SeCN)]、I、I、I 和 HOOI,以及用于破坏膜稳定性的添加剂(如卡泊芬净和皂素 A16)、抑制 DNA 合成(5-氟尿嘧啶)或螯合铁(去铁胺)。鉴于天然产物添加剂和再利用药物在 PDT 中的成功,添加剂类型的视角有望揭示一般光氧化反应增强的机制细节。事实上,如何通过添加剂增强光氧化反应的策略仍未得到充分探索。